Trials / Completed
CompletedNCT02035696
Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old
A Phase I/II, Randomized, Observer-Blind, Multicenter Study to Evaluate Immunogenicity and Safety of Four Influenza Vaccines in Healthy Pediatric Subjects 6 to < 48 Months of Age.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 671 (actual)
- Sponsor
- Seqirus · Industry
- Sex
- All
- Age
- 6 Months – 48 Months
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and immunogenicity of four influenza vaccines in children 6 months to \< 48 months of age
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Trivalent influenza vaccine (TIVc) | |
| BIOLOGICAL | Trivalent influenza vaccine-licensed | Licensed influenza vaccine |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2014-06-01
- Completion
- 2014-12-01
- First posted
- 2014-01-14
- Last updated
- 2018-07-10
- Results posted
- 2017-06-27
Locations
27 sites across 4 countries: United States, Finland, Philippines, Thailand
Source: ClinicalTrials.gov record NCT02035696. Inclusion in this directory is not an endorsement.